Insight Initiatives Pty Ltd

  ACN 089 087 623

Sydney, NSW, Australia

"Uncommon sense in the art & science of people leadership"

 Corporate Coaches & Psychologists

 Superior human solutions for business

 

 Home

 HR Services

 HR Software

 HR Courses

 Film & TV

 Psych Clinic

 Press Room

 ePsychNews

 Contact us

 

 

ePsych News

Biomedical Psychology for Personal & Corporate Health

   © Copyright Insight Matters corporate psychologists, except where otherwise indicated

 Subscribe to ePsych News:   

 

3 Billion Dollar Hoax

By Gina Kolata

An estimated 12% of Americans aged 65 and older have osteoarthritis of the knee. A popular operation for arthritis of the knee worked no better than a sham procedure in which patients were sedated while surgeons pretended to operate, researchers are reporting.

The operation, arthroscopic surgery, for the pain and stiffness caused by osteoarthritis is performed on about 650,000 people in the US every year, at a cost of about $5,000 per procedure, for a total cost of 3.3 billion dollars every year in the US. It involves making three small incisions in the knee; inserting an arthroscope, a thin instrument that allows surgeons to see the joint; and then flushing debris from the knee or shaving rough areas of cartilage from the joint and then flushing it.

Tests of knee functions revealed that the operation had not helped, and those who got the placebo surgery reported feeling just as good as those who had had the real operation.

Dr. Baruch Brody, an ethicist at Baylor who helped design the study, described the surgery as a sham.

The study dealt only with arthroscopic surgery for osteoarthritis, not with other common knee operations.

The 180 participants in the study were randomly assigned to have the operation or to have placebo surgery in which surgeons simply made cuts in their knees so the patients would not know if they had the surgery.

The research began when an orthopedic surgeon at the Houston veterans' hospital, Dr. J. Bruce Moseley, who is now the team physician for Houston's two professional basketball teams, approached Dr. Wray suggesting a study that would compare washing the knee joint with washing and scraping in patients with arthritis.

Dr. Wray had a bolder idea.  "She said, `How do you know that what you are seeing is not a placebo effect?' " Dr. Moseley recalled. "My response was, `This is surgery.' She said, `I hate to tell you this, but surgery may have the biggest placebo effect of all.' "

Placebo studies of surgery are almost never done. Many doctors consider them unethical because patients could undergo risks with no benefits. Working with Dr. Brody, the ethicist, the group tried to make the placebo treatment no more dangerous than daily life. Still, of 324 consecutive patients who were asked to participate, 144 declined.

For those who agreed, the day of surgery meant being wheeled into an operating room while neither they nor any of the medical staff knew what their treatment would be. When they were on the operating table, Dr. Moseley, who did all the operations, opened a sealed envelope telling him whether the patient was to have the surgery or not.

Those in the placebo group received a drug that put them to sleep. Unlike those getting the real operation, they did not have general anesthesia.

Dr. Moseley made small cuts in their knees to simulate an operation. He bent and straightened the knee and asked for surgical instruments, just in case the patient was partly conscious. An assistant sloshed water in a bucket to make the sound of a knee being flushed clean.

The paper in The New England Journal is accompanied by two editorials. One, by Sam Horng and Dr. Franklin G. Miller of the National Institutes of Health, asks whether placebo surgery is unethical. The controversy, they wrote, comes because doctors assume that patients in clinical research should not be put at risk if they cannot benefit, and placebo surgery involves risk.

But, they say, clinical research is different from medical therapy; its aim is not to help those in the study but to help future patients.  To be ethical, they say, a study with placebo surgery must meet three criteria: it must not place patients at undue risk; the benefits of learning whether the surgery works must be worth any potential risk to the patients; and the patients must give informed consent.

In the current case, they wrote, all those objectives were met and the study "exemplifies the ethically justified use of placebo surgery."

New York Times July 11, 2002

The New England Journal of Medicine July 11, 2002;347:81-88, 132-133


Stephanie Thompson's comments:

The title of this piece is a little harsh, because 'hoax' implies intentional deception.  This is unlikely in the vast majority of cases.  Most medical professionals are very well intentioned and, in this case in particular, one can understand surgeons' expectations that the procedure could benefit patients.

However, it is very telling, isn't it?  The notion of evidence-based medicine requires that all interventions be proven, by well designed trials, to be substantially more effective than placebo.  Surgery, in particular, often falls dramatically short of this ideal.  This is partly due to the substantial practical challenges of running surgical placebo trials, but also, yes, because there has been far much too much assuming going on. 

An underlying principle in placebo science is that the more 'song and dance' involved in an intervention, the stronger the placebo effect tends to be.  Thus procedures and medicines which produce unpleasant side effects may have larger placebo effects.  Larger pills tend to produce larger placebo responses than smaller pills.  Surgery, of course, is a particularly dramatic intervention which should be expected to create among the largest of placebo effects.  

However, evidence-based medicine is much easier said than done, especially for health practitioners in the field (as opposed to in a lab, academic office or legal practice).  What is a doctor to do when faced with a patient in obvious pain?  He/she doesn't have the luxury of running a quick placebo controlled trial on 300 people with precisely the same condition, and following them up for three years, before making a therapeutic recommendation. 

What does this all mean for clinical practice?  I have three thoughts:

1. Question, question, and question some more. Never assume that what you read, what you are told by grey-haired professors with certificates, or what you currently believe, are necessarily correct.  Knowledge is a moving target.

2. Do not make assumptions about cause and effect. A given effect can have a number of causes, so consider all possibilities.

3. Ask "What can be done to ethically harness the remarkable self-healing power of patients, to minimise their subjection to unnecessary stress, risk and costs of surgery?"  (Ideas welcome!!)

 

 

Call (+61) (0)2 9969 7775


Looking for something?


 


Keep me informed...

Register your email address with us to receive occasional news and information:

Your details will be kept strictly private and used only to deliver very occasional news or items of interest.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All material on this website is copyright Insight Initiatives Pty Ltd. Copyright applies to content, concepts and presentation.